serious adverse experience

serious adverse experience

In a clinical trial, any experience related to a therapeutic intervention that suggests a significant hazard, contraindication, side effect or the need for precautionary measures.
Mentioned in ?
References in periodicals archive ?
Finally, there is a series of annexes dealing with geographical distribution of lymphatic filariasis, onchocerciasis, schistosomiasis and soil transmitted helminthiasis, strategies for rapid assessment, standardized forms for recording serious adverse experiences, drug supply, recommended dosages and dose poles, coverage forms and disease specific information.
A total of 69% of patients in each group reported at least one adverse experience, and 1.6% of each group discontinued the medication due to serious adverse experiences. During the course of the therapy and up to 14 days' follow-up, 6 patients in the ertapenem group died, compared with 10 patients in the piperacillin/tazobactam group.